Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    respiratory

    Cryptogenic organising pneumonia

    Also known as: Cryptogenic organizing pneumonia, COP, Idiopathic organising pneumonia, Idiopathic bronchiolitis obliterans organising pneumonia (historical)

    Cryptogenic organising pneumonia (COP) is an idiopathic inflammatory interstitial lung disease characterised by an organising pneumonia pattern on histopathology or imaging in the absence of an identifiable cause. Given that clinical features—including cough, dyspnoea, fatigue, and constitutional symptoms—frequently mimic infectious pneumonia, specialist respiratory evaluation is mandatory. Standard management involves corticosteroid therapy and vigilance for relapse. TCM involvement is limited to supportive symptom management in clinically stable patients and must not delay diagnostic investigations or substitute for conventional therapy. Current citations do not provide direct evidence for the efficacy of acupuncture or herbal medicine in treating COP. Bibliometric data concerning pulmonary fibrosis do not confirm clinical efficacy, and COP must be distinguished from the separate entity of acute fibrinous and organising pneumonia. Traditional patterns serve as clinical frameworks rather than validated therapeutic protocols for this pathology.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Cessation of smoking and vaping is mandatory; avoid incense, moxa smoke, and occupational irritants. Disclose unavoidable environmental exposures to the medical team.
    • •Balance daily exertion with adequate rest; adhere strictly to exercise and pulmonary rehabilitation parameters established by the respiratory team.
    • •Maintain regular, nutritionally balanced intake and ensure hydration within prescribed clinical limits. Report unintentional weight loss or difficulty eating to the attending medical team.
    • •Prioritise attendance at all respiratory consultations. Maintain a detailed symptom diary, adhere to oxygen and pharmacological protocols, and consult with a GP or specialist regarding immunisation and infection prophylaxis.

    Cautions & Contraindications

    See sources
    • •Do not use acupuncture or herbs to postpone respiratory investigation or replace prescribed corticosteroids, oxygen or other medical care. Reference 4 reports corticosteroid responses in AFOP, not COP, and offers no evidence for substitution with TCM.[]
    • •Do not claim that the listed formulas are effective or broadly low-risk in COP: reference 1 is pulmonary-fibrosis bibliometrics, not a COP efficacy or interaction study. Full medication reconciliation, pregnancy screening and product-quality review are required before herbal treatment; these are general safety precautions rather than findings of that abstract.[]
    • •Defer elective needling and new herbal treatment during suspected respiratory infection or unexplained clinical deterioration pending medical assessment. Reference 2 supports investigation of pneumonia pathogens, not the safety of adjunctive treatment during infection.[]

    When to reassess or seek care again

    See sources

    Review any adjunctive trial after 1–2 weeks or 2–4 sessions. Record cough severity on a 0–10 scale, fatigue, sleep disruption, appetite, sputum changes and tolerance of a consistent everyday activity. Record oxygen saturation only where monitoring and thresholds have been agreed by the treating team. Stop or revise adjunctive care if there is no meaningful benefit by 4 weeks. Refer sooner for worsening function, new fever, increasing oxygen requirement or suspected relapse; imaging, lung-function follow-up and corticosteroid decisions remain with the respiratory team.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Heliyon · 2024
    2. EBioMedicine · 2025
    3. BMJ open · 2021
    4. BMC pulmonary medicine · 2019

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.